Wescott Financial Advisory Group LLC Decreases Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Wescott Financial Advisory Group LLC lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 8.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,769 shares of the financial services provider’s stock after selling 254 shares during the quarter. Wescott Financial Advisory Group LLC’s holdings in iShares Biotechnology ETF were worth $366,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the stock. HHM Wealth Advisors LLC lifted its position in iShares Biotechnology ETF by 200.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 150 shares in the last quarter. VSM Wealth Advisory LLC purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $30,000. Bradley & Co. Private Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the fourth quarter worth $32,000. Newbridge Financial Services Group Inc. purchased a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at $33,000. Finally, Hager Investment Management Services LLC acquired a new stake in iShares Biotechnology ETF during the 4th quarter valued at $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $123.79 on Friday. iShares Biotechnology ETF has a 12-month low of $122.11 and a 12-month high of $150.57. The company has a market capitalization of $5.85 billion, a price-to-earnings ratio of 27.83 and a beta of 0.84. The firm’s fifty day moving average price is $135.35 and its 200 day moving average price is $138.39.

iShares Biotechnology ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th were given a dividend of $0.1212 per share. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date was Tuesday, March 18th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.